动态对比增强灌注区域探测器CT多种数学模型评估:与FDG-PET/CT相比对非小细胞肺癌放化疗患者治疗结局的预测能力
研究纳入53例连续IIIB期非小细胞肺癌患者,在放化疗前行PET/CT和动态首过对比增强灌注区域探测器CT,比较两种方法对治疗反应、疾病进展和总生存的早期预测能力。逐步回归显示治疗反应受全身动脉灌注、总灌注和SUVmax显著影响,总灌注和全身动脉灌注与总生存显著相关。动态首过对比增强灌注区域探测器CT与PET/CT均有助于预测放化疗疗效。
要点
- 全身动脉灌注、总灌注和SUVmax依次为影响疗效的显著因素。
- 总灌注和全身动脉灌注与总生存显著相关。
- 动态首过对比增强灌注区域探测器CT与PET/CT均可预测放化疗疗效。
核心结论
- 动态首过对比增强灌注区域探测器CT与PET/CT均有助于预测接受放化疗的非小细胞肺癌患者的治疗反应。
- 治疗反应受全身动脉灌注、总灌注和SUVmax显著影响,按影响大小依次排列。
- 总灌注和全身动脉灌注对总生存的预测有显著意义。
研究设计与样本
- 研究为单中心连续纳入53例IIIB期非小细胞肺癌患者,均接受PET/CT、动态首过对比增强灌注区域探测器CT、放化疗及随访检查。
- 患者分为完全或部分缓解组与稳定或进展组。
- 采用双输入最大斜率法评估肺动脉灌注、全身动脉灌注和总灌注,Patlak图法评估渗透表面积和分布容积,单输入最大斜率法评估肿瘤灌注,并测量SUVmax,结果取平均值作为最终值。
诊断标准与关键数值
- 逐步回归分析显示治疗效应受全身动脉灌注、总灌注和SUVmax显著影响(r²=0.63,p=0.01),按影响大小依次排列。
- 总灌注对总生存的预测有显著差异(p=0.003),全身动脉灌注对总生存的预测有显著差异(p=0.04)。
临床应用与阅片要点
- 动态首过对比增强灌注区域探测器CT和PET/CT均可用于非小细胞肺癌放化疗前的治疗反应预测。
- 评估时可关注全身动脉灌注、总灌注和SUVmax,三者按影响大小依次与治疗效应相关。
- 总灌注和全身动脉灌注与总生存相关,可作为预后评估的参考指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To directly compare the capability of dynamic first-pass contrast-enhanced (CE-) perfusion area-detector CT (ADCT) and PET/CT for early prediction of treatment response, disease progression and overall survival of non-small cell carcinoma (NSCLC) patients treated with chemoradiotherapy.
MATERIALS AND METHODS: Fifty-three consecutive Stage IIIB NSCLC patients who had undergone PET/CT, dynamic first-pass CE-perfusion ADCT, chemoradiotherapy, and follow-up examination were enrolled in this study. They were divided into two groups: 1) complete or partial response (CR+PR) and 2) stable or progressive disease (SD+PD). Pulmonary arterial and systemic arterial perfusions and total perfusion were assessed at targeted lesions with the dual-input maximum slope method, permeability surface and distribution volume with the Patlak plot method, tumor perfusion with the single-input maximum slope method, and SUVmax, and results were averaged to determine final values for each patient. Next, step-wise regression analysis was used to determine which indices were the most useful for predicting therapeutic effect. Finally, overall survival of responders and non-responders assessed by using the indices that had a significant effect on prediction of therapeutic outcome was statistically compared.
RESULTS: The step-wise regression test showed that therapeutic effect (r2=0.63, p=0.01) was significantly affected by the following three factors in order of magnitude of impact: systemic arterial perfusion, total perfusion, and SUVmax. Mean overall survival showed a significant difference for total perfusion (p=0.003) and systemic arterial perfusion (p=0.04).
CONCLUSION: Dynamic first-pass CE-perfusion ADCT as well as PET/CT are useful for treatment response prediction in NSCLC patients treated with chemoradiotherapy.
引用
- Ohno Y, Fujisawa Y, Koyama H, et al. Dynamic contrast-enhanced perfusion area-detector CT assessed with various mathematical models: Its capability for therapeutic outcome prediction for non-small cell lung cancer patients with chemoradiotherapy as compared with that of FDG-PET/CT. Eur J Radiol. 2016. PMID: 28027771. doi:10.1016/j.ejrad.2016.11.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。